1-1 of 1
Yongjing Tang
Close
Sort by
Journal Articles

Phase II Study of Zanubrutinib in Combination with Rituximab and Methotrexate, Followed By Zanubrutinib Maintenance in Patients with Secondary Central Nervous System Lymphoma

Lijuan Deng, Tianheng He, Di Mei, Yongjing Tang, Changyu Lu, Xian Zhang, Meixiang Zhang, Feng Chen, Xiaopei Wang, Jun Zhu, Yuqin Song
Journal: Blood
Blood (2022) 140 (Supplement 1): 9459–9460.
https://doi.org/10.1182/blood-2022-164632
Published: 2022